Cellectar Biosciences Inc (CLRB)

[oddone33320]

Just stumbled onto this company from an article on phys.org.

This company reminds of CYTR quite a bit. If this company is/has been able to attach a chemotherapy agent to their compound to selectively "seek and destroy" cancer cells (including cancer stem cells) throughout the body and including in the brain then this will be quite an achievement in the field of cancer and very similar (but seemingly more effective) when compared to CYTR. I would not be surprised to see this developed under a fast track designation of sorts.

If management is not currently looking at developing this platform under a fast track designation then they are doing themselves, cancer patients, and their investors a disservice.

I plan to do some more DD on this company and their platform. Quite an attractive share price although still very early in development.